# BGT007 Cells for the Treatment of Refractory Digestive System Tumors

> **NCT06104241** · EARLY_PHASE1 · RECRUITING · sponsor: **The Affiliated Hospital of Xuzhou Medical University** · enrollment: 14 (estimated)

## Conditions studied

- Gastrointestinal Cancer

## Interventions

- **BIOLOGICAL:** BGT007 Injection

## Key facts

- **NCT ID:** NCT06104241
- **Lead sponsor:** The Affiliated Hospital of Xuzhou Medical University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-10-22
- **Primary completion:** 2026-10-20
- **Final completion:** 2027-10-20
- **Target enrollment:** 14 (ESTIMATED)
- **Last updated:** 2023-10-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06104241

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06104241, "BGT007 Cells for the Treatment of Refractory Digestive System Tumors". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06104241. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*